This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

11 - 13 October 2021
Webcast Series

11 - 13 October 2021
Webcast Series


best practices and case studies on successful patient engagement, recruitment and investigator site practices using novel, patient-centric and data-driven approaches

Put your burning questions to experts in the clinical industry


Connect with the Clinical Community

Patients in Clinical Trials Digital Week brings together hundreds of the clinical community to learn from some of the industry's leading experts. Make the most of the opportunity to tune into live sessions, engage with key speakers, download cutting-edge resources, and put your burning questions to the who's who in the clinical industry. And, invite your colleagues along so you can catch up after and share your thoughts.

Focused and Critical Learning

You will obtain access to information on some of the most pertinent patient-related matters in the clinical industry at present. With such a breadth of topics covered by leading representatives from across the clinical landscape, this virtual opportunity has something for everyone.

Flexible Attendance Options

Whether you're at home, in the office or elsewhere, you can participate in a webcast. Plus, we also offer the webcast sessions to all registrants on-demand for you to watch in your own time so you can recap on the sessions or, if you didn't make the live session, catch up on what you missed.

Key Themes at Patients in Clinical Trials Digital Week:

  • How decentralized trials has supported patient engagement during Covid-19 

  • Enhancing the patient experience through decentralized trials  

  • Decentralized clinical trials: Learnings from the pandemic and what’s next to support patients and investigators?  

  • The patient view on designing hybrid decentralized trials 

  • Hear from a Pharma/Biotech on patient organisation and patient centricity 

  • What are the challenges of decentralized clinical trials? 

  • Improve clinical trial experience from a patient point of view 

  • What is truly essential to ensure patient retention? 

  • KPI’s (Key Performance Indicator) - Quality assessment if undertaking patient engagement correctly? 

  • Patient engagement from the patient perspective

  • Patient trust in clinical trial data- From transparency to risk communication 

  • Will patient engagement give Industry a competitor advantage? 

  • Implementation of patient centricity in clinical development “from theory to practice” 

  • How technology has enabled companies to better collaborate and engage with patients by focusing on the patients’ needs. 

  • Increasing diversity for patient recruitment  

  • Managing recruitment expectation, the difficulty of reliable feasibility questionnaires and the need for a good recruitment strategy 

  • The application of data Science- how to get a better predictability of average recruitment and retention rate? 

  • AI tailored disease algorithms to support patient recruitment 

  • A patient-centric approach to trial recruitment, representation and retention 

  • Ensuring a good recruitment strategy - How to successfully recruit patients?

  • Using direct patient input to inform protocol design and operational execution resulting in better recruitment and retention 

  • Predicting and Improving Enrolment through Evidence, New Tech, and Creative Engagement 

  • Looking past COVID-19, will patients be more cautious and hesitant to participate in the future? 

  • How data-driven approaches can boost the recruitment processes? 

  • Diversification of your patient recruitment approach 

  • How to build the patient-centred culture across the company? 

  • What are the challenges of decentralized clinical trials? 

  • To what extend is COVID-19 impacting clinical trial recruitment? 

  • Is the impact of this pandemic on the world of clinical research uncertain for the foreseeable future?